Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
This study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate
 (a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease
 patients who are not receiving erythropoietic agents (hormones that stimulate the bone marrow
 to make more red blood cells).
Inclusion Criteria:

 -  Moderate to severe anemia

 -  Iron deficiency

 -  Moderate to severe chronic kidney disease

 Exclusion Criteria:

 -  Receiving dialysis

 -  Known sensitivity to Ferrlecit® or any of its components

 -  Receiving therapy with erythropoietic agent

 -  Clinically unstable